Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

Go back to Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.78/sh

March 5, 2020 4:05 PM EST

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.78), versus ($0.17) reported last year.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

... More